PCV140 PREFERENCE AND WILLINGNESS-TO-PAY STUDY TO ASSESS THE VALUE OF AN ANTICOAGULATION THERAPY MODELLED ON DABIGATRAN ETEXILATE USING DISCRETE CHOICE ANALYSIS- A UK PILOT STUDY OF WARFARIN-NAVE ATRIAL FIBRILLATION PATIENTS
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74667-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)74667-2/fulltext
Title :
PCV140 PREFERENCE AND WILLINGNESS-TO-PAY STUDY TO ASSESS THE VALUE OF AN ANTICOAGULATION THERAPY MODELLED ON DABIGATRAN ETEXILATE USING DISCRETE CHOICE ANALYSIS- A UK PILOT STUDY OF WARFARIN-NAVE ATRIAL FIBRILLATION PATIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74667-2&doi=10.1016/S1098-3015(10)74667-2
First page :
Section Title :
Open access? :
No
Section Order :
592